INTU vs PTGX · P/E 64, rev $18.83B vs rev $269.8M
Intuit Inc (INTU) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Intuit Inc (INTU) is a software - application company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
INTU currently screens at market cap $217.76B and trailing P/E 63.7. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the INTU and PTGX stock pages for the full models.
Not investment advice.